INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $318 | -100.0% | 5,020 | -72.0% | 0.04% | -65.5% |
| Q2 2022 | $1,022,000 | +41.4% | 17,910 | +51.5% | 0.12% | +36.5% |
| Q1 2022 | $723,000 | -11.0% | 11,820 | -45.7% | 0.08% | -12.4% |
| Q3 2021 | $812,000 | +822.7% | 21,780 | +85.9% | 0.10% | +546.7% |
| Q3 2019 | $88,000 | -58.7% | 11,716 | -2.8% | 0.02% | -53.1% |
| Q2 2018 | $213,000 | -11.2% | 12,048 | +5.6% | 0.03% | -11.1% |
| Q1 2018 | $240,000 | -7.3% | 11,408 | -36.3% | 0.04% | -21.7% |
| Q4 2017 | $259,000 | +6.1% | 17,909 | +15.9% | 0.05% | +15.0% |
| Q3 2017 | $244,000 | +2.1% | 15,446 | -2.5% | 0.04% | -37.5% |
| Q4 2016 | $239,000 | – | 15,847 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |